Search

Find here all the latest news on AFM-Telethon and rare diseases.

Find here AFM-Telethon's latest news, publications and press releases.

AFM-Telethon takes action in various fields, from research, development and bioproduction of innovative therapies for rare diseases to care for patients and their relatives. The association also advocates to defend patients’ rights and takes part in international activities. Discover our actions to fight disease.

Take part in the Telethon to give AFM-Telethon the means to conquer the disease. Discover how to participate and join us !

Discover the different ways to give to support AFM-Telethon and families' fight against rare diseases.

The Telethon, it’s a TV program combined with an exceptional momentum that gathers thousands of participants throughout France and overseas departments, that gives AFM-Telethon the means to continue its fight against disease.

AFM-Telethon is a patients' organisation fighting neuromuscular diseases, rare genetic disorders that kill muscle after muscle. Its primary goal : to conquer the disease.

Myobase is a document portal dedicated to neuromuscular diseases and motor disabilities, published by the documentation department at the French Muscular Dystrophy Association. It gives access to over 60,000 documents. 

Thanks to your donations, research is moving forwards, the first treatments have arrived and care and support for people affected by rare diseases has improved. Your donations drive the victories of AFM-Telethon!  

AFM-Telethon is battling on all fronts, from access to diagnosis and appropriate treatment to close support, giving priority to the search for innovative solutions and a response to the needs of patients. 

Encouraging innovation, creating pathways between academic research and private research, supporting those involved in developing the drug: the AFM-Telethon is investing to speed up the arrival of innovative biotherapies. 

To accelerate the development of innovative treatments for rare diseases, the AFM-Telethon has created its own laboratories. Devoted to gene therapy of rare diseases (Genethon), to stem cells (I-Stem) and to myology (Institute of myology), they are now international leaders in their field. Located within the Institute for rare disease biotherapies, the Association’s three laboratories play a major role in the medical revolution.   

Innovation in scientifical, medical, social and technological fields, AFM-Telethon is a pioneer in the research and support to improve patients’ lives. Three missions are at the heart of its action: Cure, Care, Communicate.

The French Muscular Dystrophy Association (AFM-Telethon) is an association of activists, patients and parents of patients, affected by rare, progressive and significantly disabling genetic diseases, known as genetic neuromuscular diseases. It was created out of a conviction and a desire, to cure diseases that were long considered to be incurable. AFM-Telethon is also the Telethon, a fundraising event which brought rare diseases out of scientific and medical obscurity and triggered a three-fold revolution: genetic, social and medical.  

From genome maps to the discovery of the genes responsible for diseases, an entire sector of world medicine has made a spectacular leap forward, thanks to the determination of AFM-Telethon families, and the momentum of the Telethon.